Christina Weng, MD, MBA; Mrinali Gupta, MD; Brian Do, MD, and Dimitra Skondra, MD, PhD
Show Description +
Cytomegalovirus (CMV) retinitis continues to challenge retina specialists. Could use of CMV-specific cytotoxic T lymphocytes be an effective strategy in some patients? And if so, in whom? To answer these questions, Christina Weng, MD, MBA, is joined by study author Mrinali Gupta, MD, and panelists Brian Do, MD, and Dimitra Skondra, MD, PhD. During their discussion, we hear about the structure and findings of the study and learn about how these new data may affect treatment algorithms for patients with newly diagnosed CMV retinitis.
Posted: 10/14/2021
Christina Weng, MD, MBA; Mrinali Gupta, MD; Brian Do, MD, and Dimitra Skondra, MD, PhD
Cytomegalovirus (CMV) retinitis continues to challenge retina specialists. Could use of CMV-specific cytotoxic T lymphocytes be an effective strategy in some patients? And if so, in whom? To answer these questions, Christina Weng, MD, MBA, is joined by study author Mrinali Gupta, MD, and panelists Brian Do, MD, and Dimitra Skondra, MD, PhD. During their discussion, we hear about the structure and findings of the study and learn about how these new data may affect treatment algorithms for patients with newly diagnosed CMV retinitis.
Posted: 10/14/2021
New Retina Radio is forging forward with education, and they’re partnering with Vit Buckle Society to make it happen. Check out these quick-hit reviews of journal articles delivered by VBS members.
New Retina Radio Journal Club: Treating CMV with Adoptive Immunotherapy
Christina Weng, MD, MBA; Mrinali Gupta, MD; Brian Do, MD, and Dimitra Skondra, MD, PhD
Please log in to leave a comment.